
excretion patterns urinary metabolites estradiol-4-c14 
postmenopausal women benign malignant disease breast . 
  study excretion patterns urinary metabolites 
estradiol-4-c1j administered group 43 postmenopausal women, 38 
advanced mammary carcinoma prior endocrine therapy 5 
benign mammary dysplasia, reported . chromatographic method 
employed determination estradiol, estrone, estriol 
estrogen metabolites . urinary excretion pattern defined 
(a) extent excretion isotope 3 successive 24-hr. 
collection periods, (b) percentage urinary radiometabolites 
enzymatically hydrolyzed, (c) relative concentration several 
metabolites hydrolyzed fraction . wide subject-to-subject 
variations found . metabolites estradiol, estrone, 
estriol comprised large portion total estrogens excreted . 
significantly lower amount estradiol noted group 
women mammary carcinoma compared amount found 
group women benign mammary dysplasia, suggesting former 
group metabolizes rapidly administered estradiol . although 
excretion patterns patients failed respond estrogen 
treatment (nonresponders) differed greatest patterns 
associated benign disease, distinctive patterns urinary 
excretion isotopic estrogens allowed statistically 
significant clinically useful separation responders 
nonresponders subsequent estrogen therapy discovered . 
